American Dementia: Brain Health in an Unhealthy Society
inSocialWork
JANUARY 19, 2022
Soon, Medicare will issue a decision about whether they will cover Aduhelm (Aducanumab) – the new Alzheimer’s Disease (AD) treatment – the expensive and controversial medication approved by the FDA last June with mixed support from the scientific and Alzheimer’s community. These guys shake trees.
Let's personalize your content